Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology (2016)

Peer-Reviewed Study · Finberg JP, Rabey JM. · October 18, 2016

Finberg JP et al., 2016-10-18: Review of MAO inhibitors that describes methylene blue as a reversible selective MAO-A inhibitor with antidepressant properties but with additional NOS and guanylate cyclase actions, so its antidepressant effect should not be attributed to MAO-A inhibition alone.

and so its antidepressant properties should not be solely ascribed to inhibition of MAO-A.

Finberg JP et al., 2016-10-18: Review of MAO inhibitors that describes methylene blue as a reversible selective MAO-A inhibitor with antidepressant properties but with additional NOS and guanylate cyclase actions, so its antidepressant effect should not be attributed to MAO-A inhibition alone. Study type: narrative review. N: not applicable. Country: Israel (Technion; Assaf Harofe Medical Center). Dose: none tested. Funder/conflicts not verified from the article body. Relevance to C8: confirms MAO-A inhibition as one real mechanism and explicitly denies that it is the sole explanation. Study type: review.